Clenbuterol Induces Cell Cycle Arrest in C2C12 Myoblasts by Delaying p27 Degradation through β-arrestin 2 Signaling

Int J Biol Sci. 2017 Oct 17;13(10):1341-1350. doi: 10.7150/ijbs.17948. eCollection 2017.

Abstract

β2-Adrenoceptor (β2-AR) agonists promote muscle growth. The aim of this study was to elucidate some effects of the selective β2-adrenoceptor agonist clenbuterol (CLB) on myoblast proliferation. We found that CLB induces cell cycle arrest in C2C12 myoblasts. This effect is partly due to the enhanced stability of p27, rather than the increased gene transcription via cAMP response element-binding protein (CREB). Specifically, CLB treatment enhanced the accumulation of p27 in the nucleus while depleting it from the cytosol via a mechanism that requires β2-AR. Surprisingly, p27 accumulation was not reversed by the protein kinase A (PKA) inhibitor H-89, but interestingly, was alleviated by the knockdown of β-arrestin 2. Thus, our work provides a basis for β2-AR agonists inhibit myoblasts proliferation through signaling via β2-AR, β-arrestin 2, and p27.

Keywords: cell cycle; clenbuterol; p27; β-arrestin 2.; β2-AR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Cycle Checkpoints / drug effects*
  • Cell Line
  • Clenbuterol / pharmacology*
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Myoblasts / drug effects
  • Myoblasts / metabolism
  • Signal Transduction / drug effects
  • beta-Arrestin 2 / metabolism*

Substances

  • Cyclic AMP Response Element-Binding Protein
  • beta-Arrestin 2
  • Clenbuterol